Sharma, P.; Buddhavarapu, V.; Dhillon, G.; Verma, R.K.; Devadoss, R.; Raynor, J.; Munjal, R.; Grewal, H.; Kashyap, R.
Glucagon-like Peptide-1 Receptor Agonists: Are They as Good as They Seem? A Systematic Review of Severe Adverse Effects. Endocrines 2024, 5, 323-333.
https://doi.org/10.3390/endocrines5030023
AMA Style
Sharma P, Buddhavarapu V, Dhillon G, Verma RK, Devadoss R, Raynor J, Munjal R, Grewal H, Kashyap R.
Glucagon-like Peptide-1 Receptor Agonists: Are They as Good as They Seem? A Systematic Review of Severe Adverse Effects. Endocrines. 2024; 5(3):323-333.
https://doi.org/10.3390/endocrines5030023
Chicago/Turabian Style
Sharma, Pranjal, Venkata Buddhavarapu, Gagandeep Dhillon, Ram Kishun Verma, Ramprakash Devadoss, James Raynor, Ripudaman Munjal, Harpreet Grewal, and Rahul Kashyap.
2024. "Glucagon-like Peptide-1 Receptor Agonists: Are They as Good as They Seem? A Systematic Review of Severe Adverse Effects" Endocrines 5, no. 3: 323-333.
https://doi.org/10.3390/endocrines5030023
APA Style
Sharma, P., Buddhavarapu, V., Dhillon, G., Verma, R. K., Devadoss, R., Raynor, J., Munjal, R., Grewal, H., & Kashyap, R.
(2024). Glucagon-like Peptide-1 Receptor Agonists: Are They as Good as They Seem? A Systematic Review of Severe Adverse Effects. Endocrines, 5(3), 323-333.
https://doi.org/10.3390/endocrines5030023
